FMC Corp vs T Rowe Price Group Inc — how do they compare? FMC Corp trades at $11.45 (market cap $1.36B), while T Rowe Price Group Inc trades at $119.6 (market cap $25.41B). The key difference: T Rowe Price Group Inc is far larger — about 18.7× FMC Corp's market cap, and T Rowe Price Group Inc pays the higher dividend (4.39%). Which is the better fit depends on your goals.
| FMC | TROW | |
|---|---|---|
Market Cap | $1.36B | $25.41B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $120.16 |
52-Week Low | $10.72 | $86.19 |
Enterprise Value | $5.50B | $22.12B |
Dividend Yield | 2.95% | 4.39% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
T. Rowe Price (TROW) trades at $116.07, up 2.13% with a bullish technical signal. The stock shows strong fundamentals with a P/E of 12.72, net income margin of 28.28%, and consistent earnings beats. Recent AUM growth to $1.89 trillion and strategic institutional enhancements support positive momentum. Technical indicators show the stock trading near pivot point resistance at $116 with support at $115.
TROW presents a compelling value opportunity with attractive valuation metrics and strong profitability. The primary risk remains equity outflows despite diversification efforts. Analyst consensus is cautious with 63% hold ratings, though recent Zacks upgrades to Strong Buy highlight growing optimism. The stock's current price sits above the consensus target of $109.17, suggesting limited near-term upside potential.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →